Compare $ALLO vs $TECX | Chartloom

Compare

$ALLO vs $TECX

Allogene Therapeutics Inc · Tectonic Therapeutic Inc

ALLO

Allogene Therapeutics Inc

TECX

Tectonic Therapeutic Inc

Compare $ALLO vs $TECX

Comparing Allogene Therapeutics Inc and Tectonic Therapeutic Inc

ALLOAllogene Therapeutics Inc

TECXTectonic Therapeutic Inc

ALLOAllogene Therapeutics Inc

Market cap

$504M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

39,713.68x

Rev growth (TTM)

—

YTD performance

8.1%

52W performance

-0.7%

FCF yield

-20.4%

TECXTectonic Therapeutic Inc

Market cap

$440M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

11.6%

52W performance

51.9%

FCF yield

-16.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALLO

TECX

Detailed metrics comparison

ALLO

Allogene Therapeutics Inc

TECX

Tectonic Therapeutic Inc

Market Cap

ALLO$504M

TECX$440M

Enterprise Value

ALLO$465M

TECX$213M

Price

ALLO$1.46

TECX$23.33

P/E Ratio

ALLON/A

TECXN/A

P/S Ratio

ALLO108.60x

TECX0.00x

EV/Sales

ALLO100.28x

TECX0.00x

EV/EBITDA

ALLO0.00x

TECX0.00x

P/B Ratio

ALLO1.19x

TECX1.97x

P/FCF Ratio

ALLON/A

TECXN/A

EV/FCF

ALLO-4.54x

TECX-2.95x

PEG Ratio

ALLON/A

TECXN/A

Forward P/E (NTM)

ALLON/A

TECXN/A

Forward P/S (NTM)

ALLO39,713.68x

TECXN/A

Revenue (TTM)

ALLO$5M

TECX$0

Revenue Growth (YoY)

ALLON/A

TECXN/A

Forward Rev Growth

ALLO219.7%

TECX0.0%

Gross Margin (TTM)

ALLO0.0%

TECX0.0%

Operating Margin (TTM)

ALLO0.0%

TECX0.0%

EBITDA Margin (TTM)

ALLO-2703.1%

TECX0.0%

Net Margin (TTM)

ALLO-2648.4%

TECX0.0%

FCF Margin (TTM)

ALLO-2211.2%

TECXN/A

Net Income (TTM)

ALLO$-123M

TECX$-86M

FCF (TTM)

ALLO$-103M

TECX$-72M

EPS (TTM)

ALLO-$0.37

TECX-$4.52

ROE (TTM)

ALLO-3531.0%

TECX-3526.0%

ROA (TTM)

ALLO-2622.0%

TECX-3359.0%

ROIC (TTM)

ALLO-3531.0%

TECX-3521.0%

Cash

ALLO$39M

TECX$227M

Debt

ALLO$0

TECX$186K

Net Cash/Debt

ALLO$39M

TECX$227M

Current Ratio (TTM)

ALLO10.72x

TECX22.29x

Quick Ratio (TTM)

ALLO10.55x

TECX21.90x

Debt/Equity (TTM)

ALLO0.00x

TECX0.00x

Debt/Assets (TTM)

ALLO0.0%

TECX0.0%

Interest Coverage (TTM)

ALLON/A

TECXN/A

Net Debt/EBITDA (TTM)

ALLO0.00x

TECX0.00x

Beta

ALLO0.75

TECX1.29

52W Performance

ALLO-0.7%

TECX51.9%

YTD Performance

ALLO8.1%

TECX11.6%

% from 52W High

ALLO-67.3%

TECX-41.0%

% from 52W Low

ALLO40.4%

TECX52.3%

Asset Turnover (TTM)

ALLO0.01x

TECX0.00x

FCF Yield (TTM)

ALLO-20.4%

TECX-16.4%

Earnings Yield (TTM)

ALLO-24.4%

TECX-19.5%

Dividend Yield (TTM)

ALLON/A

TECXN/A

Rule of 40

ALLO-2,211.2

TECX0.0

EV/GP/RG

ALLON/A

TECXN/A

Ticker research

View ALLO research View TECX research

Metric	ALLO Allogene Therapeutics Inc	TECX Tectonic Therapeutic Inc
Market & Valuation
Market Cap	$504M	$440M
Enterprise Value	$465M	$213M
Price	$1.46	$23.33
P/E Ratio	N/A	N/A
P/S Ratio	108.60x	0.00x
EV/Sales	100.28x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.19x	1.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.54x	-2.95x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	39,713.68x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	219.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2703.1%	0.0%
Net Margin (TTM)	-2648.4%	0.0%
FCF Margin (TTM)	-2211.2%	N/A
Net Income (TTM)	$-123M	$-86M
FCF (TTM)	$-103M	$-72M
EPS (TTM)	-$0.37	-$4.52
ROE (TTM)	-3531.0%	-3526.0%
ROA (TTM)	-2622.0%	-3359.0%
ROIC (TTM)	-3531.0%	-3521.0%
Financial Health
Cash	$39M	$227M
Debt	$0	$186K
Net Cash/Debt	$39M	$227M
Current Ratio (TTM)	10.72x	22.29x
Quick Ratio (TTM)	10.55x	21.90x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.75	1.29
52W Performance	-0.7%	51.9%
YTD Performance	8.1%	11.6%
% from 52W High	-67.3%	-41.0%
% from 52W Low	40.4%	52.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-20.4%	-16.4%
Earnings Yield (TTM)	-24.4%	-19.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,211.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALLO research	View TECX research

Valuation

P/S Ratio

TECX

0.00x

ALLO

108.60x

EV/FCF

ALLO

-4.54x

TECX

-2.95x

Growth & revenue

Forward Revenue Growth

ALLO

219.7%

TECX

0.0%

Profitability & performance

Gross Margin

ALLO

0.0%

TECX

0.0%

ROE

TECX

-3526.0%

ALLO

-3531.0%

FCF Yield %

TECX

-16.4%

ALLO

-20.4%

52-Week Performance

TECX

51.9%

ALLO

-0.7%

Detailed metrics comparison

ALLO

Allogene Therapeutics Inc

TECX

Tectonic Therapeutic Inc

Market Cap

ALLO$504M

TECX$440M

Enterprise Value

ALLO$465M

TECX$213M

Price

ALLO$1.46

TECX$23.33

P/E Ratio

ALLON/A

TECXN/A

P/S Ratio

ALLO108.60x

TECX0.00x

EV/Sales

ALLO100.28x

TECX0.00x

EV/EBITDA

ALLO0.00x

TECX0.00x

P/B Ratio

ALLO1.19x

TECX1.97x

P/FCF Ratio

ALLON/A

TECXN/A

EV/FCF

ALLO-4.54x

TECX-2.95x

PEG Ratio

ALLON/A

TECXN/A

Forward P/E (NTM)

ALLON/A

TECXN/A

Forward P/S (NTM)

ALLO39,713.68x

TECXN/A

Revenue (TTM)

ALLO$5M

TECX$0

Revenue Growth (YoY)

ALLON/A

TECXN/A

Forward Rev Growth

ALLO219.7%

TECX0.0%

Gross Margin (TTM)

ALLO0.0%

TECX0.0%

Operating Margin (TTM)

ALLO0.0%

TECX0.0%

EBITDA Margin (TTM)

ALLO-2703.1%

TECX0.0%

Net Margin (TTM)

ALLO-2648.4%

TECX0.0%

FCF Margin (TTM)

ALLO-2211.2%

TECXN/A

Net Income (TTM)

ALLO$-123M

TECX$-86M

FCF (TTM)

ALLO$-103M

TECX$-72M

EPS (TTM)

ALLO-$0.37

TECX-$4.52

ROE (TTM)

ALLO-3531.0%

TECX-3526.0%

ROA (TTM)

ALLO-2622.0%

TECX-3359.0%

ROIC (TTM)

ALLO-3531.0%

TECX-3521.0%

Cash

ALLO$39M

TECX$227M

Debt

ALLO$0

TECX$186K

Net Cash/Debt

ALLO$39M

TECX$227M

Current Ratio (TTM)

ALLO10.72x

TECX22.29x

Quick Ratio (TTM)

ALLO10.55x

TECX21.90x

Debt/Equity (TTM)

ALLO0.00x

TECX0.00x

Debt/Assets (TTM)

ALLO0.0%

TECX0.0%

Interest Coverage (TTM)

ALLON/A

TECXN/A

Net Debt/EBITDA (TTM)

ALLO0.00x

TECX0.00x

Beta

ALLO0.75

TECX1.29

52W Performance

ALLO-0.7%

TECX51.9%

YTD Performance

ALLO8.1%

TECX11.6%

% from 52W High

ALLO-67.3%

TECX-41.0%

% from 52W Low

ALLO40.4%

TECX52.3%

Asset Turnover (TTM)

ALLO0.01x

TECX0.00x

FCF Yield (TTM)

ALLO-20.4%

TECX-16.4%

Earnings Yield (TTM)

ALLO-24.4%

TECX-19.5%

Dividend Yield (TTM)

ALLON/A

TECXN/A

Rule of 40

ALLO-2,211.2

TECX0.0

EV/GP/RG

ALLON/A

TECXN/A

Ticker research

View ALLO research View TECX research

Metric	ALLO Allogene Therapeutics Inc	TECX Tectonic Therapeutic Inc
Market & Valuation
Market Cap	$504M	$440M
Enterprise Value	$465M	$213M
Price	$1.46	$23.33
P/E Ratio	N/A	N/A
P/S Ratio	108.60x	0.00x
EV/Sales	100.28x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.19x	1.97x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.54x	-2.95x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	39,713.68x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	219.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2703.1%	0.0%
Net Margin (TTM)	-2648.4%	0.0%
FCF Margin (TTM)	-2211.2%	N/A
Net Income (TTM)	$-123M	$-86M
FCF (TTM)	$-103M	$-72M
EPS (TTM)	-$0.37	-$4.52
ROE (TTM)	-3531.0%	-3526.0%
ROA (TTM)	-2622.0%	-3359.0%
ROIC (TTM)	-3531.0%	-3521.0%
Financial Health
Cash	$39M	$227M
Debt	$0	$186K
Net Cash/Debt	$39M	$227M
Current Ratio (TTM)	10.72x	22.29x
Quick Ratio (TTM)	10.55x	21.90x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.75	1.29
52W Performance	-0.7%	51.9%
YTD Performance	8.1%	11.6%
% from 52W High	-67.3%	-41.0%
% from 52W Low	40.4%	52.3%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-20.4%	-16.4%
Earnings Yield (TTM)	-24.4%	-19.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,211.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALLO research	View TECX research